syndrome and Klinefelter syndrome, to illustrate scientists' role in uncoupling gender identity and biological sex, and considers the implications of diagnostic technologies that unearth conditions with varied manifestations and unknown clinical meaning. Chapter 6 focuses on CGH (comparative genomic hybridization) and NIPT (noninvasive prenatal testing), twenty-first-century developments that extend prenatal diagnosis beyond a specific mutation to the whole genome.
Imperfect Pregnancies does not evade the critique of prenatal diagnosis as reflecting a "backdoor to eugenics" and a consumer-driven quest for a flawless child, but Löwy's careful attention to national political, institutional, and cultural differences, women's situated choices about abortion and motherhood, and the ways that "successful new technologies, such as prenatal diagnosis, produce new and often unexpected effects" (p. 4) tells a more complicated story. Rather than warning about designer babies in the future, Löwy interrogates the implications of prenatal screening technologies that are already routine. While her broad overview will surely be elaborated in future studies, especially with regard to commercial influences, malpractice law, and the impact of transgender and disability activism, Löwy's emphasis on ordinary rather than exceptional cases should encourage scholars and practitioners alike to see prenatal diagnosis in a new light. Addiction treatment has always been a controversial matter. Back in the nineteenth century there was debate about whether this was a moral or a medical matter. Then there was the question of the relationship to the criminal justice system. And what should the goal of treatment be-reduction of harm or abstinence and moral reformation? Who should pay for treatment and where should it be located? These dimensions have concerned society for decades and vary across different national cultures as well.
Claire D. Clark's The Recovery Revolution deals with addiction treatment in the United States from the 1960s to the present. Her focus is on therapeutic communities (TCs), organizations that offered residential rehabilitation services in the community. They had their origin in a democratic British model developed by psychiatrists like Maxwell Jones after the Second World War. This had some impact in U.S. prisons, but the model that flourished in the United States was different. It was exemplified by Synanon (derived from Sin Anonymous), established by Chuck Dederich in California in 1958. His confrontational methods were hierarchical, inspired by the AA (Alcoholics Anonymous) peer-led therapeutic approach.
Dederich radicalized AA, which he saw as too soft for the hardened criminalized heroin addicts who needed not only to drop their drug use but to confront the character defects that had caused it in the first place. Synanon involved intense group therapy sessions-again a model that had been developed but in a different way in the U.K. mental health system for alcohol treatment.
Media exposure was central to the expansion of TCs. Dederich wanted Synanon to become "as well-known as Coca-Cola" (p. 77). Magazines and television popularized tag lines like "hang tough," which crossed over from rehab subcultures to the political lexicon. Life magazine ran a feature on the organization in 1962. The later history of the organization as a self-declared social movement and as a corporatist new religion or "kooky cult" in the 1970s and 1980s came to symbolize the excesses of spiritual exploration and alternative living in the 1960s and 1970s. For Clark, the organization's importance lies also in the second-generation TCs it inspired, which shared in the expansion of funding for treatment that began in the late 1960s during Richard Nixon's presidency. Daytop (Drug Addicts Yield to Persuasion), Phoenix House, Odyssey House, and others developed multiple facilities.
TCs did not offer the only approach. The publication of a 1965 paper by Vincent Dole and Marie Nyswander in JAMA (Journal of the American Medical Association) betokened the rise of another treatment that came to have international influence. Dole and Nyswander viewed the craving of addiction not as the outcome of a personality defect but rather as a biological condition that could be treated with pharmaceuticals. Their research led to the reversal of the long-standing U.S. ban on maintenance treatment for opiate addiction. Nixon set up the Special Action Office for Drug Abuse Prevention (SAODAP), headed by psychiatrist Jerry Jaffe, whose reputation had been made running the IDAP program in Illinois that tested multimodal addiction treatment. In 1974, NIDA (National Institute on Drug Abuse) was set up under Robert Dupont, who had made his name with an expanding and successful methadone program in Washington, D.C. It incorporated most of the other research funding and research bodies.
Clark explores the changing fate of TCs against this background of changes in U.S. drug policy and treatment from the 1970s up to the Obama administration, from treatment to punishment and back again. TCs proved adaptable within these shifts, and their advocates reframed them as a peer-based treatment "method" rather than as residential treatment. They adapted to the rise of the "NIDA brain disease paradigm" in the late 1990s and to the rise of "recovery-oriented systems of care" under Bush and Obama.
Clark's book is a valuable guide to these developments, although its detail sometimes make it difficult to discern the overall forest from the trees. The exchange of ideas between the United States and the United Kingdom is one strand that could have been developed-Phoenix was an important model that made the Atlantic crossing.
1 And the idea of "recovery" itself, which has recently been much debated in the United Kingdom, as a new alternative to harm reduction, is never really dissected. It seems to have animated the whole U.S. drug treatment system as well as this book and its title. As one of only a few historians to explore the experience of death, dying, and chronic illness, Emily K. Abel has repeatedly challenged prevailing assumptions and conventional wisdom. In this book, she argues that there has been an overemphasis on quandary issues typically debated by bioethicists and widely reported in the media-euthanasia, physician-assisted suicide, and when to "pull the plug" on life-prolonging technologies. Much more attention, she argues, should be given to the more commonplace but no less difficult issues that patients and families inevitably confront throughout the long course of dying. The book is based on Abel's analysis of more than one hundred memoirs, published between 1965 and 2014, of family members of people who died from chronic disease. From these she distills a set of experiences that make up the typical trajectory of terminal illness: being given a diagnosis and prognosis, enrolling in clinical trials in pursuit of an elusive cure, coming to terms with the inevitable limits of biomedicine, and negotiating the complex and often hostile bureaucracies of home health care, hospitals, nursing homes, and hospice.
She argues that three historical developments shaped these experiences. First, with the creation of Medicare and Medicaid in 1965, the federal government shouldered much of the cost of health care for people with terminal illnesses. Private decisions about where and how to care for the dying became matters of intense public policy debate, and health care organizations were incentivized to structure services around streams of federal funding. Second, since the mid-1960s, expensive, high-tech interventions have become an increasingly common part of care for the dying. The third development, at odds with the other two, was the rise of a movement aimed at humanizing the care of dying people.
She also calls into question several cherished assumptions about death and dying in the modern age. Most commentators have assumed that patient autonomy has steadily increased since the 1960s, and that increasing individual choice is the foundation for good care of the dying. But Abel shows that, notwithstanding widespread demands for physician honesty and the establishment of requirements for
